Notify me when Andera Partners files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| IVA | Inventiva S.A. | Ordinary Shares, nominal value Euro 0.01 per share | 7.7% | $80,593,658 | +$10,381,814 | 14,114,476 | +15% | Andera Partners | 31 Dec 2025 |
| EVOMMUNE, INC. | Common Stock, $0.0001 par value per share | 6% | 1,897,362 | Andera Partners | 07 Nov 2025 | ||||
| MLYS | MINERALYS THERAPEUTICS, INC. | Common Stock, $0.0001 par value per share | 4.2% | $39,747,075 | 2,765,976 | Andera Partners | 30 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|